Back to search
FDAFDA · Food and drugs·Recall number D-1384-2014

Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 73502 1

Published June 25, 2014 · Recall initiated: June 12, 2014

Summary

FDA records drug Class II recall D-1384-2014, published June 25, 2014 and initiated June 12, 2014. Recalling firm: Thorne Research Inc; Status: Terminated; Reported quantity: unknown; Lot: All lot codes. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.

What to do

Voluntary: Firm initiated · Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Thorne Research Inc
Distributor
Nationwide, New Zealand, England, German, Sweden, Ukraine, and Egypt.
Lot
All lot codes
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 73502 1 recalled?

Yes. FDA published recall D-1384-2014 on June 25, 2014. Reported hazard: Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.

What should I do if I have this product?

Voluntary: Firm initiated · Visit